In a revealing interview with Dr. Jordan Peterson in February 2023, Israel’s Prime Minister Benjamin Netanyahu made a startling admission regarding the nation’s role in Pfizer’s COVID-19 vaccine development. Netanyahu acknowledged that in late 2020, he transformed Israel into a vast human “laboratory for Pfizer.”
During the interview, Netanyahu disclosed the strategic move he made to secure Pfizer’s experimental vaccines for Israel. He took pride in convincing Pfizer CEO Albert Bourla to provide Israel with a significant number of vaccine doses, enabling the country to be at the forefront of the global effort to combat COVID-19.
Netanyahu’s persuasion tactics included offering Bourla access to Israel’s extensive medical database, a resource consisting of digitized medical records for 98% of the population. This database served as a valuable tool for Pfizer to assess the impact of their vaccines on individuals.
Netanyahu explained, “I described that in my book, my conversations with Albert Bourla, Pfizer, and I persuaded him to give tiny Israel then the necessary vaccines to get us out first from the COVID.”
By exchanging the nation’s medical and genetic data for Pfizer’s vaccines, Netanyahu positioned Israel as a unique testing ground. He emphasized, “So Israel became, if you will, the lab for Pfizer, and that’s how we did it.”
This revelation sparks discussions about the ethics and implications of using an entire nation’s population as a testing ground for experimental vaccines. Netanyahu’s admission sheds light on the complex interplay between global health crises, pharmaceutical interests, and the lengths some leaders are willing to go to ensure their nation’s swift recovery from the challenges posed by the pandemic.